IGFBP-1 and its Protective Role in the Pathogenesis of Microangiopathy in Type 1 Diabetes
Authors:
M. Kršek; M. Prázný; J. Škrha; V. Justová; Z. Lacinová
Authors‘ workplace:
III. interní klinika 1. LF UK a VFN, Praha
Published in:
Čas. Lék. čes. 2001; : 234-237
Category:
Overview
Background.
The role of IGF-I/IGFBP’s system in the pathogenesis of diabetic vascular complications is widely discussed in the literature. We studied the influence of this system on microvasculare in patients with type 1 diabetes with respect to the effect of IGFBP-1.Methods and Results. 17 patients with type 1 diabetes were included in the study. We examined IGF-I, IGFBP-1 and IGFBP-3 serum levels, parameters of compensation of diabetes and basic values of lipid metabolism. The function of microvasculature was examined using the laser-Doppler system Periflux. We didn’t found any relation between the total IGF-I serum levels, parameters of lipid metabolism or level of diabetes compensation and the degree of impairment of the function of microcirculatoin. IGFBP-1 serum levels positively correlated with the peak perfusion in thermal hyperaemia (r=0.39; p
Key words:
Type 1 diabetes, microangiopathy, IGF-I, IGFBP-1, IGFBP-3, laser-doppler fluxmetry.
Labels
Addictology Allergology and clinical immunology Angiology Audiology Clinical biochemistry Dermatology & STDs Paediatric gastroenterology Paediatric surgery Paediatric cardiology Paediatric neurology Paediatric ENT Paediatric psychiatry Paediatric rheumatology Diabetology Pharmacy Vascular surgery Pain management Dental HygienistArticle was published in
Journal of Czech Physicians
Most read in this issue
- Fire-Eater’s Pneumonia: Differential Diagnosis
- IGFBP-1 and its Protective Role in the Pathogenesis of Microangiopathy in Type 1 Diabetes
- Foot Care as Recommended by the International Consensus on the Diabetic Foot
- Diabetes Control by Pump Insulin Therapy